Le Lézard
Classified in: Health
Subject: FDA

Jenkins Eye Care Offers First and Only FDA-approved Trifocal Lens: AcrySof IQ PanOptix Trifocal IOL

HONOLULU, Sept. 9, 2019 /PRNewswire/ -- Ophthalmological surgeons Tyrie Jenkins, M.D. and Jeffrey Peterson, M.D., Ph.D., of Jenkins Eye Care, now offer cataract patients a trifocal lens that provides a combination of near, intermediate and distance vision. This lens is also an option for people 50 years and older wanting to reduce or eliminate their need for contacts or glasses.  

Jeffrey R. Peterson, M.D., Ph.D.

Dr. Peterson implanted his first trifocal lens on Thursday, Sept. 5. He is among the earliest in Hawaii to do so.

The first to receive U.S. Food and Drug Administration approval of a trifocal lens for lens replacement during cataract surgery, the AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL) significantly reduces the need for glasses after surgery. It is made by Alcon.

"Ophthalmologists across the nation have been anticipating FDA approval of the trifocal lens for patients," said Dr. Peterson. "This cutting-edge lens improves range of vision. We are pleased to be among the first to offer it in Hawaii."

"For those who don't have cataracts but want to reduce their dependence on eyeglasses and contact lenses, the trifocal lens benefits are revolutionary," Dr. Jenkins added.

About Cataracts
A cataract is clouding in the natural lens of the eye. As a cataract develops, the eye's lens gradually becomes hard and cloudy, allowing in less light, making it difficult to see. Cataracts generally result from aging, but radiation exposure, taking steroids, diabetes, and eye trauma can accelerate development. Cataracts are the most common age-related eye condition and leading cause of preventable blindness. Twenty million in the U.S., age 40 and older have cataracts. Cataracts are treated by removing the eye's cloudy natural lens and surgically replacing it with an intraocular lens. More than 98 percent of cataract surgeries are considered successful, and patients typically can return to regular routines within 24 hours.

About Presbyopia
Presbyopia is a common, age-related vision condition in which the eye gradually loses the ability to focus on close objects. Almost everyone will experience presbyopia to some degree as they age, with symptoms first appearing as people enter their 40s and worsening into their 60s. In the U.S., an estimated 112 million experience vision issues due to presbyopia ? a number that's expected to continue increasing. The condition is not a disease, so there is not a cure. However, there are safe and effective ways to correct presbyopia, including eyeglasses, contact lenses, or refractive surgery.

For more information, contact Jenkins Eye Care at (808) 591-9911 or online at www.jenkinseyecare.com.

Media Contact:
Barbra Pleadwell
bap@hastingsandpleadwell.com ? (808) 292-3031

Tyrie Jenkins, M.D.

SOURCE Jenkins Eye Care

These press releases may also interest you

at 08:58
The Parkinson's Foundation is pleased to announce the addition of five new sites for PD GENEration: Mapping the Future of Parkinson's Disease, a first-of-its-kind national initiative that offers free genetic testing and counseling for clinically...

at 08:55
It seems that every new report on projected revenues in the cannabis markets, global and U.S and North America, all seem to agree on one thing: The cannabidiol (CBD) revolution will continue to rise. An industry insider, Technavio, who has been...

at 08:55
Verantos, the market leader in regulatory-grade real world evidence (RWE) studies, today announced that it has received a grant from the National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), to support...

at 08:54
A recent review of integration data from OrganicPaymentGateways.com showed a roughly 3:2 ratio of CBD site owners who chose Shopify Inc. vs CBD site owners who chose WooCommerce. WooCommerce and Shopify Inc. dominate the e-commerce market,...

at 08:53
International automotive technology supplier ERM Advanced Telematics (https://ermtelematics.com/), whose products are installed in more than 5 million vehicles worldwide, has identified the huge global pharmaceutical market as a potential opportunity...

at 08:53
OrthoGrid Systems, Inc., a global medtech leader in alignment technology for orthopedic surgery, announces today that its newest application, PhantomMSK Trauma, has received 510(K) clearance from the U.S. Food and Drug Administration (FDA)....

News published on 9 september 2019 at 15:56 and distributed by: